Early Stage Development for Solid Dose Products

Watch this webcast to review challenges experienced in early stage development of solid oral dosage forms and the implications of these challenges on a development program.

Listen to our experts discuss common hurdles, such as:

Bioavailability challenges of poorly soluble molecules early on in development
Development of paediatric dosage forms
The complexity of the CMC work stream from early development to commercial supply

Authors:
Kaspar Van den Dries, Senior Director Formulation Sciences
Michiel Heslinga, Program Manager, Global Integration

Related Sites

Additional Resources

© 2021 Thermo Fisher Scientific Inc. All rights reserved. Cookie Use Privacy Terms of Use Modern Slavery Statement

Cookie Use Privacy Terms of Use Modern Slavery Statement

© 2021 Thermo Fisher Scientific Inc. All rights reserved.